Posts

Cochrane Review Finds Anti-Amyloid Alzheimer's Drugs Lack Clinically Meaningful Effect, Sparking Debate

Korsana Biosciences Goes Public Through Reverse Merger with Cyclerion Therapeutics

Korsana Biosciences Launches with $175M to Develop Brain-Penetrant Alzheimer's Antibody